BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3768870)

  • 1. Phase II study of rDNA alpha-2 interferon (INTRON A) in patients with multiple myeloma utilizing an escalating induction phase.
    Case DC; Sonneborn HL; Paul SD; Hiebel J; Boyd MA; Shepp MA; Dorsk BM; Bonnem E
    Cancer Treat Rep; 1986 Nov; 70(11):1251-4. PubMed ID: 3768870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha-2-interferon/melphalan/prednisone in previously untreated patients with multiple myeloma: a phase I-II trial.
    Cooper MR; Fefer A; Thompson J; Case DC; Kempf R; Sacher R; Neefe J; Bickers J; Scarffe JH; Spiegel R
    Cancer Treat Rep; 1986 Apr; 70(4):473-6. PubMed ID: 3698041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II study of rDNA human alpha-2 interferon in multiple myeloma.
    Wagstaff J; Loynds P; Scarffe JH
    Cancer Treat Rep; 1985 May; 69(5):495-8. PubMed ID: 4005872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The addition of interferon or high dose cyclophosphamide to standard chemotherapy in the treatment of patients with multiple myeloma: phase III Eastern Cooperative Oncology Group Clinical Trial EST 9486.
    Oken MM; Leong T; Lenhard RE; Greipp PR; Kay NE; Van Ness B; Keimowitz RM; Kyle RA
    Cancer; 1999 Sep; 86(6):957-68. PubMed ID: 10491521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical trial of alpha-interferon (human lymphoblastoid interferon) in combination with VCAP chemotherapy in multiple myeloma].
    Umeda M; Shirai T; Tsukahara T; Kaneko H; Yamauchi M; Arai N; Kosuge T; Kato M; Shikoshi K; Anno S
    Rinsho Ketsueki; 1991 Jun; 32(6):669-74. PubMed ID: 1890744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Results of treatment of patients with advanced multiple myeloma with the vincristine-adriamycin-dexamethasone protocol].
    Marisavljević D; Bosković D; Radosević N; Elezović I; Tomin D; Gotić M; Antunović P
    Srp Arh Celok Lek; 1996; 124(11-12):292-6. PubMed ID: 9132962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II study of human lymphoblastoid interferon in patients with multiple myeloma.
    Cox EB; Laszlo J; Krown S; Mintzer D; Sarna G
    J Biol Response Mod; 1988 Jun; 7(3):318-25. PubMed ID: 3392554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I-II trial on natural beta interferon in chemoresistant and relapsing multiple myeloma.
    Liberati AM; Cinieri S; Senatore MG; Portuesi MG; De Angelis V; Di Clemente F; Schippa M; Ferrajoli A; Arzano S; Berruto P
    Haematologica; 1990; 75(5):436-42. PubMed ID: 2129033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human leukocyte interferon and intermittent high-dose melphalan-prednisone administration in the treatment of multiple myeloma: a randomized clinical trial from the Myeloma Group of Central Sweden.
    Ahre A; Björkholm M; Mellstedt H; Brenning G; Engstedt L; Gahrton G; Gyllenhammar H; Holm G; Johansson B; Järnmark M
    Cancer Treat Rep; 1984 Nov; 68(11):1331-8. PubMed ID: 6388832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunomodulation by recombinant interferon-alpha 2 in a phase I trial in patients with lymphoproliferative malignancies.
    Ozer H; Gavigan M; O'Malley J; Thompson D; Dadey B; Nussbaum-Blumenson A; Snider C; Rudnick S; Ferraresi R; Norred S
    J Biol Response Mod; 1983; 2(6):499-515. PubMed ID: 6607323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical trial of a combination of human lymphoblastoid interferon (HLBI) and methyl-prednisolone (HLBI-mP) in multiple myeloma].
    Fukuzawa Y; Kawamura T; Ohno R
    Gan To Kagaku Ryoho; 1989 Nov; 16(11):3581-6. PubMed ID: 2817909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I study of alpha 2-interferon plus doxorubicin in patients with solid tumors.
    Sarosy GA; Brown TD; Von Hoff DD; Spiegel RJ; Golando JP; Beougher KL; Kuhn JG; Kisner DL
    Cancer Res; 1986 Oct; 46(10):5368-71. PubMed ID: 3756887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant alpha-interferon therapy in multiple myeloma.
    Anand AS; Shah PM; Parikh BJ; Shah SA; Patel KM; Shukla SN; Talati SS; Patel AR
    Indian J Cancer; 1990 Dec; 27(4):203-7. PubMed ID: 2090574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fludarabine + prednisone +/- alpha-interferon followed or not by alpha-interferon maintenance therapy for previously untreated patients with chronic lymphocytic leukemia: long term results of a randomized study.
    Mauro FR; Zinzani P; Zaja F; Gentile M; Vegna ML; Stefoni V; Marin L; Fanin R; Baccarani M; Tura S; Mandelli F
    Haematologica; 2003 Dec; 88(12):1348-57. PubMed ID: 14687987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of multiple myeloma with recombinant human leukocyte A interferon.
    Ohno R; Kimura K; Amaki I; Imamura Y; Masaoka T; Miyazaki T; Yoshida Y; Miura Y; Maekawa T; Oguro M
    Cancer Treat Rep; 1985 Dec; 69(12):1433-5. PubMed ID: 4075317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of a multicenter randomized phase II trial of thalidomide and prednisone maintenance therapy for multiple myeloma after autologous stem cell transplant.
    Stewart AK; Chen CI; Howson-Jan K; White D; Roy J; Kovacs MJ; Shustik C; Sadura A; Shepherd L; Ding K; Meyer RM; Belch AR
    Clin Cancer Res; 2004 Dec; 10(24):8170-6. PubMed ID: 15623591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II study of oral methyl-CCNU and prednisone in previously treated alkylating agent-resistant multiple myeloma.
    Tornyos K; Silberman H; Solomon A
    Cancer Treat Rep; 1977 Aug; 61(5):785-7. PubMed ID: 329977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination therapy with thalidomide and dexamethasone in patients with newly diagnosed multiple myeloma not undergoing upfront autologous stem cell transplantation: a phase II trial.
    Dingli D; Rajkumar SV; Nowakowski GS; Gertz MA; Dispenzieri A; Lacy MQ; Hayman S; Fonseca R; Lust JA; Kyle RA; Greipp PR; Witzig TE
    Haematologica; 2005 Dec; 90(12):1650-4. PubMed ID: 16330438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous melphalan, thalidomide and prednisone in refractory and relapsed multiple myeloma.
    Palumbo A; Avonto I; Bruno B; Ambrosini MT; Bringhen S; Cavallo F; Falco P; Boccadoro M
    Eur J Haematol; 2006 Apr; 76(4):273-7. PubMed ID: 16519697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II study of paclitaxel and epirubicin as first-line therapy in patients with metastatic breast cancer.
    Lück HJ; Thomssen C; du Bois A; Untch M; Lisboa B; Köhler G; Diergarten K
    Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-35-S17-39. PubMed ID: 9374090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.